Uncomplicated Nausea and Vomiting in the Emergency Department

NCT00778011 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 137

Last updated 2012-06-28

No results posted yet for this study

Summary

Nausea and vomiting is a common complaint in the emergency department. Treatment is important for many reasons. In addition to patient comfort, there are adverse effects secondary to vomiting such as dehydration, metabolic alkalosis, Mallory-Weiss tears, and aspiration. Two mediations common used for nausea in ED patients include Ondanesetron and Metoclopramide.

Conditions

Interventions

DRUG

Ondansetron

dosage

DRUG

Ondansetron

4 mg

DRUG

Metoclopramide

10 mg IV

Sponsors & Collaborators

  • WellSpan Health

    lead OTHER

Principal Investigators

  • Marc Pollack, MD, PhD · York Hospital Emergency Department Physician

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-11-30
Primary Completion
2006-12-31
Completion
2006-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00778011 on ClinicalTrials.gov